Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Relative defects in mucosal immunity predict acute graft-versus-host disease.

August KJ, Chiang KY, Qayed M, Dulson A, Worthington-White D, Cole CR, Horan JT.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1056-9. doi: 10.1016/j.bbmt.2014.03.012. Epub 2014 Mar 15.

PMID:
24641826
[PubMed - in process]
3.

Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.

Transpl Immunol. 2006 Jan;15(3):223-7. Epub 2005 Nov 28.

PMID:
16431290
[PubMed - indexed for MEDLINE]
4.

High alpha-1 antitrypsin clearance predicts severity of gut graft-versus-host disease (GVHD) in children.

Hagen LE, Schechter T, Luk Y, Brodovitch A, Gassas A, Doyle JJ.

Pediatr Transplant. 2011 Sep;15(6):659-63. doi: 10.1111/j.1399-3046.2011.01553.x. Epub 2011 Jul 29.

PMID:
21797957
[PubMed - indexed for MEDLINE]
5.

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, Penack O, Na IK, Liu C, Murphy G, Alpdogan O, Blumberg RS, Macian F, Holmes KV, Beauchemin N, van den Brink MR.

PLoS One. 2011;6(7):e21611. doi: 10.1371/journal.pone.0021611. Epub 2011 Jul 6.

PMID:
21760897
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009159. doi: 10.1002/14651858.CD009159.pub2. Review.

PMID:
22972135
[PubMed - indexed for MEDLINE]
7.

Reduced incidence of acute graft versus host disease (GVHD) of the gut in Chinese carriers of Helicobacter pylori during allogeneic bone marrow transplantation.

Au WY, Wong RW, Wong BC, Lie AK, Liang R, Leung AY, Kwong YL.

Ann Hematol. 2004 Jan;83(1):34-7. Epub 2003 Oct 10.

PMID:
14551739
[PubMed - indexed for MEDLINE]
8.

Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients.

Johansson JE, Ekman T.

Dig Dis Sci. 2007 Sep;52(9):2340-5. Epub 2007 Apr 6.

PMID:
17415646
[PubMed - indexed for MEDLINE]
9.

Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.

PMID:
23074497
[PubMed]
Free PMC Article
10.

Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.

Dean RM, Fry T, Mackall C, Steinberg SM, Hakim F, Fowler D, Odom J, Foley J, Gress R, Bishop MR.

J Clin Oncol. 2008 Dec 10;26(35):5735-41. doi: 10.1200/JCO.2008.17.1314. Epub 2008 Nov 10.

PMID:
19001329
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Gut mucosal mast cells and goblet cells during acute graft-versus-host disease in rats.

Levy DA, Wefald A.

Ann Inst Pasteur Immunol. 1986 Sep-Oct;137D(2):281-8.

PMID:
3541968
[PubMed - indexed for MEDLINE]
12.

Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Avanzini MA, Maccario R, Locatelli F, Giebel S, Santos CD, Bernardo ME, Pagliara D, Montagna D, Longo S, Amendola G, Marconi M.

Exp Hematol. 2006 Oct;34(10):1429-34.

PMID:
16982336
[PubMed - indexed for MEDLINE]
13.

Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Hossain MS, Jaye DL, Pollack BP, Farris AB, Tselanyane ML, David E, Roback JD, Gewirtz AT, Waller EK.

J Immunol. 2011 Nov 15;187(10):5130-40. doi: 10.4049/jimmunol.1101334. Epub 2011 Oct 17.

PMID:
22013117
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.

Goldberg J, Jacobsohn DA, Zahurak ML, Vogelsang GB.

Biol Blood Marrow Transplant. 2005 Feb;11(2):101-7.

PMID:
15682070
[PubMed - indexed for MEDLINE]
15.

Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.

Rupa-Matysek J, Lewandowski K, Nowak W, SawiƄski K, Gil L, Komarnicki M.

Transplant Proc. 2011 Jun;43(5):1915-23. doi: 10.1016/j.transproceed.2011.02.011.

PMID:
21693300
[PubMed - indexed for MEDLINE]
16.

LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MR.

Blood. 2004 Feb 15;103(4):1542-7. Epub 2003 Oct 16.

PMID:
14563643
[PubMed - indexed for MEDLINE]
Free Article
17.

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y.

Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.

PMID:
20109568
[PubMed - indexed for MEDLINE]
18.

[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].

Lin Q, Dong M, Wang QM, Wen JY, Wu XY.

Ai Zheng. 2006 Oct;25(10):1261-5. Chinese.

PMID:
17059772
[PubMed - indexed for MEDLINE]
19.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
[PubMed - indexed for MEDLINE]
20.

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

Ho VT, Aldridge J, Kim HT, Cutler C, Koreth J, Armand P, Antin JH, Soiffer RJ, Alyea EP.

Biol Blood Marrow Transplant. 2009 Jul;15(7):844-50. doi: 10.1016/j.bbmt.2009.03.017.

PMID:
19539216
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk